Genetic, Biochemical, and Structural Characterization of CMY-136 β-Lactamase, a Peculiar CMY-2 Variant
- 21 February 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 5 (4) , 528-538
Abstract
With the widespread use and abuse of antibiotics for the past decades, antimicrobial resistance poses a serious threat to public health nowadays. β-Lactams are the most used antibiotics, and β-lactamases the most widespread resistance mechanism. Class C β-lactamases, also known as cephalosporinases, usually do not hydrolyse the latest and most potent β-lactams, expanded spectrum cephalosporins and carbapenems. However, the recent emergence of extended-spectrum AmpC cephalosporinases, their resistance to inhibition by classic β-lactamase inhibitors, and the fact that they can contribute to carbapenem resistance when paired with impermeability mechanisms, means that these enzymes may still prove worrisome in the future. Here we report and characterize the CMY-136 β-lactamase, a Y221H point mutant derivative of CMY-2. CMY-136 confers an increased level of resistance to ticarcillin, cefuroxime, cefotaxime and ceftolozane/tazobactam. It is also capable of hydrolysing ticarcillin and cloxacillin, which act as inhibitors of CMY-2. X-ray crystallography and modelling experiments suggest that the hydrolytic profile alterations seem to be the result of an increased flexibility and altered conformation of the Ω-loop, caused by the Y221H mutation.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-10-LABX-33, ANR-14-JAMR-0002)
- R?gion Ile-de-France
This publication has 37 references indexed in Scilit:
- Beta-lactamase database (BLDB) – structure and functionJournal of Enzyme Inhibition and Medicinal Chemistry, 2017
- Structural and Functional Aspects of Extended-Spectrum AmpC Cephalosporinases.Current Drug Targets, 2016
- Increased Hydrolysis of Oximino-β-Lactams by CMY-107, a Tyr199Cys Mutant Form of CMY-2 Produced by Escherichia coliAntimicrobial Agents and Chemotherapy, 2015
- Dissemination of the chromosomally encoded CMY-2 cephalosporinase gene in Escherichia coli isolated from animalsInternational Journal of Antimicrobial Agents, 2015
- Complete Sequences of Six IncA/C Plasmids of Multidrug-Resistant Salmonella enterica subsp. enterica Serotype NewportMicrobiology Resource Announcements, 2015
- Contribution of asparagine 346 residue to the carbapenemase activity of CMY-2 β-lactamaseFEMS Microbiology Letters, 2013
- Enhancing Resistance to Cephalosporins in Class C β-Lactamases: Impact of Gly214Glu in CMY-2Biochemistry, 2010
- AmpC β-LactamasesClinical Microbiology Reviews, 2009
- Naturally Occurring Extended-Spectrum Cephalosporinases in Escherichia coliAntimicrobial Agents and Chemotherapy, 2006
- Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coliPlasmid, 1984